1205 related articles for article (PubMed ID: 32947866)
21. Alterations of the Predominant Fecal Microbiota and Disruption of the Gut Mucosal Barrier in Patients with Early-Stage Colorectal Cancer.
Liu X; Cheng Y; Shao L; Ling Z
Biomed Res Int; 2020; 2020():2948282. PubMed ID: 32280686
[TBL] [Abstract][Full Text] [Related]
22. Biodiversity and richness shifts of mucosa-associated gut microbiota with progression of colorectal cancer.
Pan HW; Du LT; Li W; Yang YM; Zhang Y; Wang CX
Res Microbiol; 2020; 171(3-4):107-114. PubMed ID: 31982498
[TBL] [Abstract][Full Text] [Related]
23. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
Yu LC
J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
[TBL] [Abstract][Full Text] [Related]
24. Impact of Laparoscopic Sleeve Gastrectomy on Gut Permeability in Morbidly Obese Subjects.
Kellerer T; Brandl B; Büttner J; Lagkouvardos I; Hauner H; Skurk T
Obes Surg; 2019 Jul; 29(7):2132-2143. PubMed ID: 30903427
[TBL] [Abstract][Full Text] [Related]
25. Characterizing the gut microbiota in patients with chronic kidney disease.
Hu X; Ouyang S; Xie Y; Gong Z; Du J
Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
[No Abstract] [Full Text] [Related]
26. Evaluation and comparison of short chain fatty acids composition in gut diseases.
Niccolai E; Baldi S; Ricci F; Russo E; Nannini G; Menicatti M; Poli G; Taddei A; Bartolucci G; Calabrò AS; Stingo FC; Amedei A
World J Gastroenterol; 2019 Sep; 25(36):5543-5558. PubMed ID: 31576099
[TBL] [Abstract][Full Text] [Related]
27. Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer.
Fan X; Jin Y; Chen G; Ma X; Zhang L
Digestion; 2021; 102(4):508-515. PubMed ID: 32932258
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiota, inflammatory bowel disease and colorectal cancer.
Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
[TBL] [Abstract][Full Text] [Related]
29. Gut mycobiome: A promising target for colorectal cancer.
Qin X; Gu Y; Liu T; Wang C; Zhong W; Wang B; Cao H
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188489. PubMed ID: 33278512
[TBL] [Abstract][Full Text] [Related]
30. The Dynamic Changes of Gut Microbiota in
Wu M; Wu Y; Li J; Bao Y; Guo Y; Yang W
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30231491
[TBL] [Abstract][Full Text] [Related]
31. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
32. Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer.
Lin C; Cai X; Zhang J; Wang W; Sheng Q; Hua H; Zhou X
Digestion; 2019; 100(1):72-78. PubMed ID: 30332668
[TBL] [Abstract][Full Text] [Related]
33. Gut microbiota-derived metabolites in CRC progression and causation.
Dalal N; Jalandra R; Bayal N; Yadav AK; Harshulika ; Sharma M; Makharia GK; Kumar P; Singh R; Solanki PR; Kumar A
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3141-3155. PubMed ID: 34273006
[TBL] [Abstract][Full Text] [Related]
34. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
Xu KY; Xia GH; Lu JQ; Chen MX; Zhen X; Wang S; You C; Nie J; Zhou HW; Yin J
Sci Rep; 2017 May; 7(1):1445. PubMed ID: 28469156
[TBL] [Abstract][Full Text] [Related]
35. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.
Maccioni L; Gao B; Leclercq S; Pirlot B; Horsmans Y; De Timary P; Leclercq I; Fouts D; Schnabl B; Stärkel P
Gut Microbes; 2020 Nov; 12(1):1782157. PubMed ID: 32588725
[TBL] [Abstract][Full Text] [Related]
36. Impact of gut microbiota on plasma oxylipins profile under healthy and obesogenic conditions.
Ávila-Román J; Arreaza-Gil V; Cortés-Espinar AJ; Soliz-Rueda JR; Mulero M; Muguerza B; Arola-Arnal A; Arola L; Torres-Fuentes C
Clin Nutr; 2021 Apr; 40(4):1475-1486. PubMed ID: 33743282
[TBL] [Abstract][Full Text] [Related]
37. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.
Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J
Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860
[TBL] [Abstract][Full Text] [Related]
38. Gut microbiota in patients after surgical treatment for colorectal cancer.
Jin Y; Liu Y; Zhao L; Zhao F; Feng J; Li S; Chen H; Sun J; Zhu B; Geng R; Wei Y
Environ Microbiol; 2019 Feb; 21(2):772-783. PubMed ID: 30548192
[TBL] [Abstract][Full Text] [Related]
39. Diabetic cats have decreased gut microbial diversity and a lack of butyrate producing bacteria.
Kieler IN; Osto M; Hugentobler L; Puetz L; Gilbert MTP; Hansen T; Pedersen O; Reusch CE; Zini E; Lutz TA; Bjørnvad CR
Sci Rep; 2019 Mar; 9(1):4822. PubMed ID: 30886210
[TBL] [Abstract][Full Text] [Related]
40. Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity.
Sun G; Yin Z; Liu N; Bian X; Yu R; Su X; Zhang B; Wang Y
Biochem Biophys Res Commun; 2017 Nov; 493(2):964-970. PubMed ID: 28942145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
